[
  {
    "ts": null,
    "headline": "Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced the submission of a supplemental New Drug Application/sNDA to the US FDA for its schizophrenia drug called CAPLYTA (lumateperone). The submission is based on long-term Phase 3 clinical data demonstrating CAPLYTA’s safety and […]",
    "url": "https://finnhub.io/api/news?id=3d81316f9f3132daac3a9038ee9af5d5d319bd9d7745399a5727d1fb93698c6f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752162025,
      "headline": "Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data",
      "id": 135855734,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced the submission of a supplemental New Drug Application/sNDA to the US FDA for its schizophrenia drug called CAPLYTA (lumateperone). The submission is based on long-term Phase 3 clinical data demonstrating CAPLYTA’s safety and […]",
      "url": "https://finnhub.io/api/news?id=3d81316f9f3132daac3a9038ee9af5d5d319bd9d7745399a5727d1fb93698c6f"
    }
  },
  {
    "ts": null,
    "headline": "UBS Maintains a Buy on Genmab (GMAB) With a DKK2,500 PT",
    "summary": "Genmab A/S (NASDAQ:GMAB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 25, UBS analyst Xian Deng maintained a Buy rating on Genmab A/S (NASDAQ:GMAB) and set a price target of DKK2,500.00. The company reported $715 million in revenue for the first three months of 2025 compared to $603 million […]",
    "url": "https://finnhub.io/api/news?id=d00c2451e58b9a7164d140f06be9a4efeca2dd70938cad20163b91569ccb6a42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752160442,
      "headline": "UBS Maintains a Buy on Genmab (GMAB) With a DKK2,500 PT",
      "id": 135855735,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Genmab A/S (NASDAQ:GMAB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 25, UBS analyst Xian Deng maintained a Buy rating on Genmab A/S (NASDAQ:GMAB) and set a price target of DKK2,500.00. The company reported $715 million in revenue for the first three months of 2025 compared to $603 million […]",
      "url": "https://finnhub.io/api/news?id=d00c2451e58b9a7164d140f06be9a4efeca2dd70938cad20163b91569ccb6a42"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump",
    "summary": "Trump revives tariff threats on pharma imports, but industry giants like LLY and JNJ stay unfazed with major U.S. investments underway.",
    "url": "https://finnhub.io/api/news?id=df287e40eb727c86c9092cf435149978e345a0469131169198519a9fb2846e4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752154440,
      "headline": "Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump",
      "id": 135853558,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Trump revives tariff threats on pharma imports, but industry giants like LLY and JNJ stay unfazed with major U.S. investments underway.",
      "url": "https://finnhub.io/api/news?id=df287e40eb727c86c9092cf435149978e345a0469131169198519a9fb2846e4e"
    }
  },
  {
    "ts": null,
    "headline": "Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?",
    "summary": "HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.",
    "url": "https://finnhub.io/api/news?id=97aaa85da616b95705eb608d25bf7c5d2cb0bea0dbca2dba389095a9a3536b09",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752150300,
      "headline": "Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?",
      "id": 135855738,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.",
      "url": "https://finnhub.io/api/news?id=97aaa85da616b95705eb608d25bf7c5d2cb0bea0dbca2dba389095a9a3536b09"
    }
  },
  {
    "ts": null,
    "headline": "These Are The Most Overvalued And Undervalued Mega Cap Stocks",
    "summary": "These Are The Most Overvalued And Undervalued Mega Cap Stocks",
    "url": "https://finnhub.io/api/news?id=5d1188996de610d85b617148b91a54f4e10a95dc28b96e263ef778afb7ab47a9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752144489,
      "headline": "These Are The Most Overvalued And Undervalued Mega Cap Stocks",
      "id": 135853176,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5d1188996de610d85b617148b91a54f4e10a95dc28b96e263ef778afb7ab47a9"
    }
  },
  {
    "ts": null,
    "headline": "Dow rallies nearly 125 points on gains for shares of McDonald's, Nike",
    "summary": "Dow rallies nearly 125 points on gains for shares of McDonald's, Nike",
    "url": "https://finnhub.io/api/news?id=7d70f1182af7ad9c266d06eee190f891e5302d2a9ee02bbbc05dcfa743058ada",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752142620,
      "headline": "Dow rallies nearly 125 points on gains for shares of McDonald's, Nike",
      "id": 135949172,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Dow rallies nearly 125 points on gains for shares of McDonald's, Nike",
      "url": "https://finnhub.io/api/news?id=7d70f1182af7ad9c266d06eee190f891e5302d2a9ee02bbbc05dcfa743058ada"
    }
  },
  {
    "ts": null,
    "headline": "3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies",
    "summary": "I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. View the full analysis here.",
    "url": "https://finnhub.io/api/news?id=4342310aa20b4bea536434e9e6a6836406580eff81050f694d88d945eb8aacf4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752135424,
      "headline": "3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies",
      "id": 135849782,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/693468492/image_693468492.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. View the full analysis here.",
      "url": "https://finnhub.io/api/news?id=4342310aa20b4bea536434e9e6a6836406580eff81050f694d88d945eb8aacf4"
    }
  }
]